南模生物跌4.09% 2021年上市即巅峰募16.5亿元

Core Viewpoint - Nanmo Biology's stock price has declined significantly, currently trading at 54.64 yuan, representing a drop of 4.09%, and is in a state of loss since its IPO [1] Company Overview - Nanmo Biology was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on December 28, 2021, with an initial stock issuance of 19.49 million shares at a price of 84.62 yuan per share [1] - The stock reached its highest price of 82.00 yuan on its first trading day [1] Fundraising and Financials - The total amount raised from the initial public offering (IPO) was 1.649 billion yuan, with a net amount of 1.468 billion yuan after deducting issuance costs [1] - The net fundraising amount exceeded the original plan by 1.068 billion yuan [1] - The company planned to raise 400 million yuan for various projects, including a biological research base and the development of genetically modified animal models [1] - The total issuance costs for the IPO were 181 million yuan, with underwriting fees amounting to 158 million yuan [1]